Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Scryb Inc RYMDF


Primary Symbol: C.SCYB Alternate Symbol(s):  SCYRF

Scryb Inc. is a technology company that provides its platform to power businesses and technologies with applied intelligence, real-time analytics, and actionable insights. The Company’s technologies include Cybeats, FRR, and Pharmatrac. Cybeats is an integrated security platform designed to secure and protect high-valued connected devices. The Fionet Platform is an end-to-end, rapid testing and tracking solution for community-based or decentralized settings. Combining a fast, handheld point-of-need device connected in real time to cloud data services, the Fionet Platform handles scheduling and registration via phone app at home, on-site check-in, rapid, on-the-spot antigen testing, and anonymized data and stats for dashboards for authorized stakeholders. Pharmatrac, an AI healthcare company, provides insight into medication behavior. The Company’s platform enables customers across industries to create, enhance and power disruptive solutions.


CSE:SCYB - Post by User

Comment by HomerAndCompanyon Jul 06, 2021 8:44am
118 Views
Post# 33498049

RE:Moving higher on decent volume

RE:Moving higher on decent volumeI'd like to think that news of a positive trial outcome is on the horizon.

Another possibility is the NCIB annoucement starting to get some traction. When you combine the buyback with the fact that insiders have been buying in recent months it makes sense that there shouldn't be much downside left, but plenty of upside.

goldens wrote: Perhaps some good news on the horizon???? Trial is supposed to end Friday.


<< Previous
Bullboard Posts
Next >>